Compare Johnson & Johnson (JNJ) vs SK Hynix (SKHY) Price & Performance

Johnson & JohnsonTrade

SK HynixTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs SK Hynix — how do they compare? Johnson & Johnson trades at $261.07 (market cap $618.09B), while SK Hynix trades at $169.71 (market cap $891.31B). The key difference: SK Hynix is the larger of the two by market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and SK Hynix for 10 Days on average.

	JNJ	SKHY
Market Cap	$618.09B	$891.31B
Volume	6,050,983	22,268,296
Sector	Health	Technology
52-Week High	$278.43	$198.63
52-Week Low	$186.00	$126.79
Typical Hold Time	129 Days	10 Days
Enterprise Value	$646.37B	$841.45B
Dividend Yield	2.09%	0.06%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.

JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.

SK Hynix

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JNJ

82% Buy18% Sell

Avg holding period · 129 Days

SKHY

79% Buy21% Sell

Avg holding period · 10 Days

Top news

Latest headlines on both assets

JNJ

Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growthGordon Thompson · 9 hours agoNeutral Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.24/7 Wall Street · 12 hours agoNeutral New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.PRNewsWire · 13 hours agoBullish View details →

SKHY

SK hynix upgraded to Buy on strong 5-year demand visibility and undervaluation amid AI-driven growth.Seeking Alpha · 1 day agoBullish SK Hynix shares drop 4% on earnings caution despite strong AI demand and tight memory supply.24/7 Wall Street · 3 days agoBearish View details →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

About SK Hynix

SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.